e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Clinical aspects in pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease
R. Tachikawa, K. Nagata, A. Sakurai, S. Nanjo, K. Otsuka, K. Murase, R. Kaji, Y. Takeshima, M. Hayashi, N. Katakami, K. Tomii, H. Ueda (Japan)
Source:
Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Session:
Clinical aspects in pulmonary fibrosis
Session type:
Thematic Poster Session
Number:
4190
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Tachikawa, K. Nagata, A. Sakurai, S. Nanjo, K. Otsuka, K. Murase, R. Kaji, Y. Takeshima, M. Hayashi, N. Katakami, K. Tomii, H. Ueda (Japan). Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease. Eur Respir J 2010; 36: Suppl. 54, 4190
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on acute decompensated pulmonary hypertension
Related content which might interest you:
Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Clinical features and predictive factors for acute exacerbation of idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis
Year: 2007
Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis
Source: ERJ Open Res, 6 (4) 00261-2019; 10.1183/23120541.00261-2019
Year: 2020
Clinical features of acute exacerbation in chronic birdfancier‘s lung
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006
Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features
Source: Eur Respir J 2006; 27: 143-150
Year: 2006
Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
Potential causes of acute deterioration in patients with interstitial lung disease
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Difference of the clinical characteristics and outcome between interstitial lung disease with dermatomyositis and idiopathic interstitial pneumonia
Source: International Congress 2017 – Lung function testing
Year: 2017
Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia
Source: Eur Respir J 2013; 41: 402-409
Year: 2013
Association of systemic inflammation with clinical recovery in patients with acute exacerbation of COPD
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011
Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia.
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease
Source: Eur Respir Rev 2009; 18: 129-132
Year: 2009
Clinical features of usual interstitial pneumonia-correlation between idiopathic pulmonary fibrosis and connective tissue disease associated with usual interstitial pneumonia
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
Source: Eur Respir J 2011; 37: 356
Year: 2011
Clinical and functional characteristics of patients with acute severe COPD with or without ischemic heart disease
Source: Eur Respir J 2006; 28: Suppl. 50, 162s
Year: 2006
Comparison of clinical features between patients of lung cancer with combined pulmonary fibrosis and emphysema syndrome and those with interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19.
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021
Clinical characteristics and prognosis of fibrotic nonspecific interstitial pneumonia
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept